Yüklüyor......
Identification of circadian clock modulators from existing drugs
Chronic circadian disruption due to shift work or frequent travel across time zones leads to jet‐lag and an increased risk of diabetes, cardiovascular disease, and cancer. The development of new pharmaceuticals to treat circadian disorders, however, is costly and hugely time‐consuming. We therefore...
Kaydedildi:
| Yayımlandı: | EMBO Mol Med |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5938619/ https://ncbi.nlm.nih.gov/pubmed/29666146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201708724 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|